Prolonged sulforaphane treatment does not enhance tumorigenesis in oncogenic K-ras and xenograft mouse models of lung cancer

Prolonged sulforaphane treatment does not enhance tumorigenesis in oncogenic K-ras and xenograft mouse models of lung cancer

Background: Sulforaphane (SFN), an activator of nuclear factor erythroid-2 related factor 2 (Nrf2), is a promising chemopreventive agent which is undergoing clinical trial for several diseases. Studies have indicated that there is gain of Nrf2 function in lung cancer and other solid tumors because o...

Full description

Bibliographic Details
Main Authors: Ponvijay Kombairaju, Jinfang Ma, Rajesh K Thimmulappa, G Shengbin Yan, Edward Gabrielson, Anju Singh, Shyam Biswal
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2012-01-01
Series:Journal of Carcinogenesis
Subjects:
EGFR
Keap1
K-ras
lung cancer
Nrf2
sulforaphane
Online Access:http://www.carcinogenesis.com/article.asp?issn=1477-3163;year=2012;volume=11;issue=1;spage=8;epage=8;aulast=Kombairaju

Internet

http://www.carcinogenesis.com/article.asp?issn=1477-3163;year=2012;volume=11;issue=1;spage=8;epage=8;aulast=Kombairaju

Similar Items